% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Demmert:283152,
author = {T. T. Demmert$^*$ and K. L. Pomykala and H. Lanzafame$^*$
and K. M. Pabst$^*$ and K. Lueckerath$^*$ and J. Siveke$^*$
and L. Umutlu and H. Hautzel$^*$ and R. Hamacher$^*$ and K.
Herrmann$^*$ and W. P. Fendler$^*$},
title = {{O}ncologic {S}taging with 68{G}a-{FAPI} {PET}/{CT}
{D}emonstrates a {L}ower {R}ate of {N}onspecific {L}ymph
{N}ode {F}indings {T}han 18{F}-{FDG} {PET}/{CT}.},
journal = {Journal of nuclear medicine},
volume = {64},
number = {12},
issn = {0097-9058},
address = {New York, NY},
publisher = {Soc.},
reportid = {DKFZ-2023-01938},
pages = {1906-1909},
year = {2023},
note = {2023 Dec 1;64(12):1906-1909},
abstract = {Nonspecific lymph node uptake on 18F-FDG PET/CT imaging is
a significant pitfall for tumor staging. Fibroblast
activation protein α expression on cancer-associated
fibroblasts and some tumor cells is less sensitive to acute
inflammatory stimuli, and fibroblast activation
protein-directed PET may overcome this limitation. Methods:
Eighteen patients from our prospective observational study
underwent 18F-FDG and 68Ga fibroblast activation protein
inhibitor (FAPI) PET/CT scans within a median of 2 d (range,
0-22 d). Lymph nodes were assessed on histopathology and
compared with SUV measurements. Results: On a per-patient
basis, lymph nodes were rated malignant in 10 $(56\%)$
versus 7 $(39\%)$ patients by 18F-FDG PET/CT versus
68Ga-FAPI PET/CT scans, respectively, with a respective
accuracy of $55\%$ versus $94\%$ for true lymph node
metastases. Five of 6 $(83\%)$ false-positive nodes on the
18F-FDG PET/CT scans were rated true negative by the
68Ga-FAPI PET/CT scans. On a per-lesion basis, tumor
detection rates were similar (85/89 lesions, $96\%).$
Conclusion: 68Ga-FAPI PET/CT imaging demonstrated higher
accuracy for true nodal involvement and therefore has the
potential to replace 18F-FDG PET/CT imaging for cancer
staging.},
keywords = {18F-FDG PET/CT (Other) / 68Ga-FAPI PET/CT (Other) / lymph
node staging (Other) / oncologic staging (Other)},
cin = {ED01},
ddc = {610},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37734836},
doi = {10.2967/jnumed.123.265751},
url = {https://inrepo02.dkfz.de/record/283152},
}